Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Okazaki, N.
Right arrow Articles by Koga, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okazaki, N.
Right arrow Articles by Koga, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 7, 1139-1148, July 2002
© 2002 Oxford University Press

CANCER BIOLOGY

Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation

Noriko Okazaki,1, Naomi Takahashi, Shin-ichi Kojima, Yasuhiko Masuho and Hisashi Koga,1,2

Helix Research Institute, 1532-3 Yana, Kisarazu-city, Chiba, 292-0812, Japan

Protocadherins are a major subfamily of the cadherin superfamily, but little is known about their functions and intracellular signal transduction. We cloned a novel human protocadherin gene, containing seven EC domains, and identified functional aspects of this gene. The gene was predominantly expressed in liver, kidney and colon tissues, and was thus designated Protocadherin LKC. The expression of Protocadherin LKC is markedly reduced in cancers arising from these tissues at both transcriptional and protein levels. To investigate the effects of Protocadherin LKC expression in colon cancer, we introduced the gene into colon cancer cell line HCT116, which does not express this gene. Significantly, Protocadherin LKC expression induced contact inhibition of cell proliferation although it did not affect growth rate. When grown to post-confluence in monolayer cells cultures, Protocadherin LKC-expressing HCT116 no longer formed multiple cell layers and showed the typical paving stone morphology of normal epithelial cells. Furthermore, expression of Protocadherin LKC suppressed tumor formation of HCT116 cells in a nude mouse model. In addition, we identified a protein, hMAST205 (microtubule-associated serine/threonine kinase-205 kDa), which interacted with Protocadherin LKC; the interaction occurring between the PDZ domain of hMAST205 and C-terminal tail of Protocadherin LKC. Our results suggest that Protocadherin LKC, which directly binds PDZ protein, is a molecular switch for contact inhibition of epithelial cells in the liver, kidney and colon tissues.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Z. Fu, J. Kim, A. Vidrich, T. W. Sturgill, and S. M. Cohn
Intestinal cell kinase, a MAP kinase-related kinase, regulates proliferation and G1 cell cycle progression of intestinal epithelial cells
Am J Physiol Gastrointest Liver Physiol, October 1, 2009; 297(4): G632 - G640.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. J. Otto, S. R. McCorkle, J. Hover, C. Conaco, J.-J. Han, S. Impey, G. S. Yochum, J. J. Dunn, R. H. Goodman, and G. Mandel
A New Binding Motif for the Transcriptional Repressor REST Uncovers Large Gene Networks Devoted to Neuronal Functions
J. Neurosci., June 20, 2007; 27(25): 6729 - 6739.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Imoto, H. Izumi, S. Yokoi, H. Hosoda, T. Shibata, F. Hosoda, M. Ohki, S. Hirohashi, and J. Inazawa
Frequent Silencing of the Candidate Tumor Suppressor PCDH20 by Epigenetic Mechanism in Non-Small-Cell Lung Cancers.
Cancer Res., May 1, 2006; 66(9): 4617 - 4626.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. Wang, H. J. Lee, D. S. Cooper, L. Cebotaro, P. D. Walden, I. Choi, and C. C. Yun
Coexpression of MAST205 inhibits the activity of Na+/H+ exchanger NHE3
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F428 - F437.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Ohuchida, K. Mizumoto, N. Ishikawa, K. Fujii, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka
The Role of S100A6 in Pancreatic Cancer Development and Its Clinical Implication as a Diagnostic Marker and Therapeutic Target
Clin. Cancer Res., November 1, 2005; 11(21): 7785 - 7793.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. Jiang, D. Dean, R. C. Burghardt, and A. R. Parrish
Disruption of Cadherin/Catenin Expression, Localization, and Interactions During HgCl2-Induced Nephrotoxicity
Toxicol. Sci., July 1, 2004; 80(1): 170 - 182.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Marchesini, W. Osta, J. Bielawski, C. Luberto, L. M. Obeid, and Y. A. Hannun
Role for Mammalian Neutral Sphingomyelinase 2 in Confluence-induced Growth Arrest of MCF7 Cells
J. Biol. Chem., June 11, 2004; 279(24): 25101 - 25111.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
K. J. Johnson, A. Zecevic, and E. J. Kwon
Protocadherin {alpha}3 Acts at Sites Distinct from Classic Cadherins in Rat Testis and Sperm
Biol Reprod, February 1, 2004; 70(2): 303 - 312.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.